Clinical and Biological Characteristics of Hidradenitis Suppurativa

Description

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

Conditions

Hidradenitis Suppurativa

Study Overview

Study Details

Study overview

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

Clinical and Biological Characteristics of Hidradenitis Suppurativa

Clinical and Biological Characteristics of Hidradenitis Suppurativa

Condition
Hidradenitis Suppurativa
Intervention / Treatment

-

Contacts and Locations

San Francisco

University of California, San Francisco, San Francisco, California, United States, 94115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age 13 years or older
  • 2. Diagnosis of HS clinically-confirmed by a physician
  • 1. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.

Ages Eligible for Study

13 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of California, San Francisco,

Haley B Naik, MD, MHSc, FAAD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

2026-07-15